| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/1756-185X.12888 |
| P698 | PubMed publication ID | 27135916 |
| P50 | author | Zatollah Asemi | Q39525312 |
| P2093 | author name string | Mohsen Taghizadeh | |
| Modjtaba Emadi-Baygi | |||
| Maryam Tajabadi-Ebrahimi | |||
| Parvaneh Jafari | |||
| Batol Zamani | |||
| Hamid R Golkar | |||
| Shima Farshbaf | |||
| Mohammad R Memarzadeh | |||
| Reyhaneh Akhavan | |||
| P2860 | cites work | Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. | Q51329765 |
| Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial. | Q51348369 | ||
| Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. | Q51486234 | ||
| Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis. | Q53035221 | ||
| Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4 | Q56548977 | ||
| Effect of Probiotics on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials | Q28080687 | ||
| Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury | Q28291782 | ||
| The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay | Q29616616 | ||
| Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial | Q33523412 | ||
| Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator | Q33671233 | ||
| Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor | Q33850658 | ||
| Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis | Q34101968 | ||
| Oral intake of Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 prevents collagen-induced arthritis in mice | Q34520591 | ||
| Effects of Probiotic Supplementation on Pancreatic β-cell Function and C-reactive Protein in Women with Polycystic Ovary Syndrome: A Randomized Double-blind Placebo-controlled Clinical Trial | Q35293427 | ||
| Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis | Q35553035 | ||
| Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. | Q35781569 | ||
| Metabolic diseases and pro- and prebiotics: Mechanistic insights | Q36299339 | ||
| Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity | Q36536589 | ||
| Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans | Q36720230 | ||
| Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. | Q37132054 | ||
| Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content | Q37254289 | ||
| Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease | Q37859679 | ||
| Vascular calcification in rheumatoid arthritis: prevalence, pathophysiological aspects and potential targets | Q38019107 | ||
| Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management | Q38063148 | ||
| Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy | Q38271745 | ||
| An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties | Q39804998 | ||
| Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial | Q40212931 | ||
| Acid and bile tolerance and cholesterol removal ability of lactobacilli strains | Q45182959 | ||
| Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities | Q45207579 | ||
| Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes | Q45781579 | ||
| Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects | Q46116503 | ||
| Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial | Q48067718 | ||
| The effects of probiotic bacteria on glycaemic control in overweight men and women: a randomised controlled trial. | Q51326452 | ||
| P433 | issue | 9 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| placebo | Q269829 | ||
| probiotics | Q1816730 | ||
| P304 | page(s) | 869-879 | |
| P577 | publication date | 2016-05-02 | |
| P1433 | published in | International Journal of Rheumatic Diseases | Q15764244 |
| P1476 | title | Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial | |
| P478 | volume | 19 |
| Q39026607 | Altered gut microbiota in RA: implications for treatment |
| Q89705320 | Anti-inflammatory Diet In Rheumatoid Arthritis (ADIRA)-a randomized, controlled crossover trial indicating effects on disease activity |
| Q92743663 | Associations between higher egg consumption during pregnancy with lowered risks of high blood pressure and gestational diabetes mellitus |
| Q89801253 | Can Probiotic Supplements Improve Outcomes in Rheumatoid Arthritis? |
| Q55294689 | Current Insights in Microbiome Shifts in Sjogren's Syndrome and Possible Therapeutic Interventions. |
| Q89560820 | Design of an anti-inflammatory diet (ITIS diet) for patients with rheumatoid arthritis |
| Q60954896 | Diet, Microbiota, and Gut Permeability-The Unknown Triad in Rheumatoid Arthritis |
| Q55363098 | Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study. |
| Q47810617 | Effects of oral Lactobacillus administration on antioxidant activities and CD4+CD25+forkhead box P3 (FoxP3)+ T cells in NZB/W F1 mice |
| Q53828369 | Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial. |
| Q93052272 | Environmental Exposures and Autoimmune Diseases: Contribution of Gut Microbiome |
| Q44009737 | Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something. |
| Q44042761 | Intestinal Lactobacillus in health and disease, a driver or just along for the ride? |
| Q38757039 | Intestinal dysbiosis and probiotic applications in autoimmune diseases. |
| Q46114963 | Managing Rheumatoid Arthritis with Dietary Interventions |
| Q38661283 | Oral Probiotics Alter Healthy Feline Respiratory Microbiota. |
| Q57812807 | Probiotics in Autoimmune and Inflammatory Disorders |
| Q64910852 | Probiotics in Extraintestinal Diseases: Current Trends and New Directions. |
| Q41912764 | Synbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial |
| Q65000095 | The Effect of Orally Administered Probiotics on the Behavioral, Cellular, and Molecular Aspects of Adjuvant-Induced Arthritis. |
| Q47343245 | The beneficial effects of probiotic administration on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial |
| Q49557929 | The effects of probiotics on total cholesterol: A meta-analysis of randomized controlled trials |
| Q54959766 | The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. |
| Q47206984 | The efficacy of probiotic supplementation in rheumatoid arthritis: a meta-analysis of randomized, controlled trials |
| Q92736091 | The role of microbiome in rheumatoid arthritis treatment |
| Q50134012 | The role of the gut microbiome in systemic inflammatory disease. |
| Q46463927 | The therapeutic effect of probiotics on rheumatoid arthritis: a systematic review and meta-analysis of randomized control trials |
Search more.